These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16107715)
1. Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone. Ying H; Furuya F; Willingham MC; Xu J; O'Malley BW; Cheng SY Mol Cell Biol; 2005 Sep; 25(17):7687-95. PubMed ID: 16107715 [TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone receptor-specific interactions with steroid receptor coactivator-1 in the pituitary. Sadow PM; Koo E; Chassande O; Gauthier K; Samarut J; Xu J; O'Malley BW; Seo H; Murata Y; Weiss RE Mol Endocrinol; 2003 May; 17(5):882-94. PubMed ID: 12576486 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor. Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244 [TBL] [Abstract][Full Text] [Related]
4. Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice. Cheng SY Steroids; 2005; 70(5-7):450-4. PubMed ID: 15862829 [TBL] [Abstract][Full Text] [Related]
5. Modulation by steroid receptor coactivator-1 of target-tissue responsiveness in resistance to thyroid hormone. Kamiya Y; Zhang XY; Ying H; Kato Y; Willingham MC; Xu J; O'Malley BW; Cheng SY Endocrinology; 2003 Sep; 144(9):4144-53. PubMed ID: 12933689 [TBL] [Abstract][Full Text] [Related]
6. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance. Miller LD; McPhie P; Suzuki H; Kato Y; Liu ET; Cheng SY Genome Biol; 2004; 5(5):R31. PubMed ID: 15128445 [TBL] [Abstract][Full Text] [Related]
7. A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone. Wu SY; Cohen RN; Simsek E; Senses DA; Yar NE; Grasberger H; Noel J; Refetoff S; Weiss RE J Clin Endocrinol Metab; 2006 May; 91(5):1887-95. PubMed ID: 16464943 [TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors. Vella KR; Ramadoss P; Costa-E-Sousa RH; Astapova I; Ye FD; Holtz KA; Harris JC; Hollenberg AN Mol Cell Biol; 2014 May; 34(9):1564-75. PubMed ID: 24550004 [TBL] [Abstract][Full Text] [Related]
9. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. Weiss RE; Xu J; Ning G; Pohlenz J; O'Malley BW; Refetoff S EMBO J; 1999 Apr; 18(7):1900-4. PubMed ID: 10202153 [TBL] [Abstract][Full Text] [Related]
10. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer. Ying H; Willingham MC; Cheng SY Oncogene; 2008 Jan; 27(6):823-30. PubMed ID: 17653082 [TBL] [Abstract][Full Text] [Related]
11. Specificity of thyroid hormone receptor subtype and steroid receptor coactivator-1 on thyroid hormone action. Sadow PM; Chassande O; Gauthier K; Samarut J; Xu J; O'Malley BW; Weiss RE Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E36-46. PubMed ID: 12388168 [TBL] [Abstract][Full Text] [Related]
12. In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice. Alonso M; Goodwin C; Liao X; Ortiga-Carvalho T; Machado DS; Wondisford FE; Refetoff S; Weiss RE Endocrinology; 2009 Aug; 150(8):3927-34. PubMed ID: 19406944 [TBL] [Abstract][Full Text] [Related]
13. A novel mutation (E333D) in the thyroid hormone beta receptor causing resistance to thyroid hormone syndrome. Maraninchi M; Bourcigaux N; Dace A; El-Yazidi C; Malezet-Desmoulins C; Krempf M; Torresani J; Margotat A Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):569-76. PubMed ID: 17177139 [TBL] [Abstract][Full Text] [Related]
14. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Yan J; Yu CT; Ozen M; Ittmann M; Tsai SY; Tsai MJ Cancer Res; 2006 Nov; 66(22):11039-46. PubMed ID: 17108143 [TBL] [Abstract][Full Text] [Related]
15. Tissue responses to thyroid hormone in a kindred with resistance to thyroid hormone harboring a commonly occurring mutation in the thyroid hormone receptor beta gene (P453T). Wu SY; Sadow PM; Refetoff S; Weiss RE J Lab Clin Med; 2005 Aug; 146(2):85-94. PubMed ID: 16099238 [TBL] [Abstract][Full Text] [Related]
17. A new mutation in the thyroid hormone receptor gene of a Chinese family with resistance to thyroid hormone. Dong Q; Gong CX; Gu Y; Su C Chin Med J (Engl); 2011 Jun; 124(12):1835-9. PubMed ID: 21740842 [TBL] [Abstract][Full Text] [Related]
18. Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling. Furuya F; Guigon CJ; Zhao L; Lu C; Hanover JA; Cheng SY Mol Cell Biol; 2007 Sep; 27(17):6116-26. PubMed ID: 17606624 [TBL] [Abstract][Full Text] [Related]
19. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis. Kato Y; Ying H; Willingham MC; Cheng SY Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697 [TBL] [Abstract][Full Text] [Related]